News

Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
January newsletterJanuary newsletterRexgenero secures Innovate UK grantRexgenero secures Innovate UK grantPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsPress Release: CGT Catapult and CombiGene sign agreement to develop manufacturing process for novel gene therapy to treat epilepsyPress Release: CGT Catapult and CombiGene sign agreement to develop manufacturing process for novel gene therapy to treat epilepsyGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityPress release: CGT Catapult announces vector production agreement with AdaptimmunePress release: CGT Catapult announces vector production agreement with AdaptimmuneCEO Keith Thompson speaks to reporter Katy Haswell for the NHS Alliance programme – In Search of WellnessCEO Keith Thompson speaks to reporter Katy Haswell for the NHS Alliance programme – In Search of WellnessRegulatory news - December 2017Regulatory news - December 2017December newsletterDecember newsletterGrowth in UK cell and gene therapy industry continues for fifth year runningGrowth in UK cell and gene therapy industry continues for fifth year runningPress release: CGT Catapult to collaborate with Oxford MEStar and AK (Suzhou) Biomedical as part of Jiangsu-UK industrial challenge programmePress release: CGT Catapult to collaborate with Oxford MEStar and AK (Suzhou) Biomedical as part of Jiangsu-UK industrial challenge programmeRegulatory news - November 2017Regulatory news - November 2017